Ruben Laukkonen

Director of the Flourishing Intelligence Program at the University of Oxford; Senior Researcher in Oxford’s Psychiatry Department

Data updated

Papers

5 publications

Trials

0 clinical trials

Links

Research Footprint

Ruben Laukkonen appears in 5 tracked papers (2018–2025), most studied alongside Ayahuasca, Psilocybin and LSD, across Substance Use Disorders (SUD), Anxiety Disorders and Depressive Disorders.

Most-cited paper: Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment (49 citations).

Frequent co-authors: Christopher Timmermann, Alaina Doss and Manoj Doss.

Background & Research

Ruben Laukkonen is a cognitive scientist and researcher focused on consciousness, insight, meditation, and artificial intelligence. His biography states that he completed a PhD on the cognitive science of insight at The University of Queensland, did postdoctoral research in Amsterdam, and later held an associate professorship before founding the Flourishing Intelligence Program at Oxford. He has also contributed to psychedelic research as a co-author on papers about insight and therapeutic effects.

Key Impact

He is a cognitive scientist whose work connects insight, meditation, and psychedelic states, and he co-authored several influential papers on insight and psychedelics.

5

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

9 collaborators· click a node to visit their profile

Full network →

Affiliations

Institutions, companies, and organisations Ruben Laukkonen is associated with.